An Unfinished Agenda My Life in the Pharmaceutical Industry at Meripustak

An Unfinished Agenda My Life in the Pharmaceutical Industry

Books from same Author: K Anji Reddy

Books from same Publisher: Penguin

Related Category: Author List / Publisher List


  • Retail Price: ₹ 699/- [ 3.00% off ]

    Seller Price: ₹ 678

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 3.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 3.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)K Anji Reddy
    PublisherPenguin
    ISBN9780670087808
    Pages280
    BindingHardcover
    LanguageEnglish
    Publish YearJanuary 2015

    Description

    Penguin An Unfinished Agenda My Life in the Pharmaceutical Industry by K Anji Reddy

    From his birth in a village in Andhra to founding and running Dr. Reddy's Laboratories, now one of India's largest pharmaceutical enterprises, Dr K. Anji Reddy's journey makes for an inspiring story. That story is told rivetingly in his own words in his memoir, An Unfinished Agenda. Dr Anji Reddy became an entrepreneur at a time when India was woefully short of technology to manufacture many basic medicines. Then, in barely three decades, the Indian pharmaceutical industry had grown to the point that India not only became self-sufficient in medicine, but also a supplier of affordable generic medicines to the world. Dr Anji Reddy provides a ringside view of this remarkable transformation, with fascinating anecdotes about those who made it happen. The history of modern medicine is a gripping story of triumphs and failures. An Unfinished Agenda takes the reader on a whirlwind tour of the science of medicine over the last hundred years and reminds us of the stark challenges that remain.